摘要
目的:研究我院脑血管畸形患者的用药情况。方法:利用药历管理软件统计我院2007~2009年脑血管畸形患者使用药品的数量与金额,采用限定日剂量法计算用药频度(DDDs)、限定日费用,以及消耗金额与DDDs的序号比。结果:近三年来,DDDs和金额排名基本未发生变化,DDC和序号比变化也较小,DDDs排名靠前的药物绝大多数都是对症治疗的药物。结论:脑血管畸形患者的药物治疗集中于对症治疗。治疗方案相对稳定。
Objective: To evaluate the drug use for patients with cerebral vascular malformation in Beijing Tiantan Hospital. Method:The amount and sum of drugs were summarized and analyzed. DDDs, DDC and B/A were calculated. Result:In the recent three years, DDDs, DDC, B/A and amounts of drugs have changed slightly in the treatment of patients with cerebral vascular malformation. The front-ranking DDDs drugs were mainly those used for the symptomatic treatment. Conclusion: The drug use for the treatment of patients with cerebral vascular malformation was reasonable in our hospital. The treatments were relatively stable.
出处
《药物流行病学杂志》
CAS
2011年第1期42-44,共3页
Chinese Journal of Pharmacoepidemiology